Form 4: ANI Pharmaceuticals CEO Nikhil Lalwani Sells Shares in Multiple Transactions
SEC Form 4
ANI Pharmaceuticals' CEO, Nikhil Lalwani, recently sold shares of the company's common stock in a series of transactions.
Summary
- Nikhil Lalwani, the President & CEO of ANI Pharmaceuticals, sold shares of the company's common stock on March 6, 2024, March 7, 2024, and March 8, 2024.
- On March 6, 2024, he sold 28,965 shares at a weighted average price of $65.52.
- On March 7, 2024, 17,060 shares were withheld for tax purposes related to the vesting of restricted stock.
- On March 8, 2024, he sold 16,292 shares at a weighted average price of $67.13.
- Following these transactions, Lalwani directly owns 411,629 shares of ANI Pharmaceuticals' common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports stock sales by the CEO, which could be for various personal financial reasons and doesn't necessarily reflect a negative outlook on the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CEO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Nikhil Lalwani sold 28,965 shares of ANI Pharmaceuticals common stock. |
| 03/07/2024 | 17,060 shares were withheld for tax purposes related to vesting of restricted stock. |
| 03/08/2024 | Nikhil Lalwani sold 16,292 shares of ANI Pharmaceuticals common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.